Clinical Trial Update: Normobaric Hyperoxygenation for Prevention of Contrast Induced Nephropathy [NA]

View source ↗

Summary

This entry reports a clinical trial investigating whether normobaric hyperoxygenation can prevent contrast-induced nephropathy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Nephropathy | NA | Status: UNKNOWN